NCT01243255已完成不适用
Centralized Pan-European Survey on the Undertreatment of Hypercholesterolemia. Polish Survey on the Efficacy of the Hypercholesterolemia Treatment
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 1,500
- 主要终点
- establish the proportion of patients on lipid lowering pharmacological treatment reaching the LDL-C goals according to ESC 2007 guidelines in general.
研究概览
简要总结
The purpose of the survey is to evaluate the efficacy of treatment of hypercholesterolemia in Polish patients who are currently on lipid- lowering pharmacological therapy . Efficient treatment is defined as achievement of the LDL cholesterol level goals according to the European Society of Cardiology 2007 guidlines.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients on lipid lowering drug treatment
- •Lipid lowering drug treatment lasting at least 3 months
- •No lipid lowering drug/dose change for a minimum 6 weeks prior to enrolment to the study
排除标准
- •Lack of patient's signed informed consent form
- •Lack of the blood sample taken for lipid profile and glucose within 10 days before or after assessment of the patient
结局指标
主要结局
establish the proportion of patients on lipid lowering pharmacological treatment reaching the LDL-C goals according to ESC 2007 guidelines in general.
时间窗: whole study procedure takes place during the one, single patient's visit
次要结局
- identify determinants (patient and physician characteristics) for undertreatment of hypercholesterolemia.(whole study procedure takes place during the one, single patient's visit)
- establish the proportion of patients on lipid lowering pharmacological treatment in primary prevention, reaching the LDL-C goals according to ESC 2007 guidelines for this sub-population(whole study procedure takes place during the one, single patient's visit)
- establish the proportion of patients on lipid lowering pharmacological treatment in secondary prevention, reaching the LDL-C goals according to ESC 2007 guidelines for this sub-population(whole study procedure takes place during the one, single patient's visit)
研究者
相似试验
已完成
不适用
Pan-European Survey on the Under Treatment of HypercholesterolemiaHypercholesterolemiaNCT00542867AstraZeneca6,500
已完成
不适用
Centralised Pan-Algerian Survey on the Undertreatment of HypercholesterolemiaHypertensionHypercholesterolemiaPeripheral Arterial DiseaseDiabetesCardiovascular DiseaseCoronary Heart DiseaseNCT01768403AstraZeneca1,236
已完成
不适用
Centralized Pan-Russian Survey on the Undertreatment of HypercholesterolemiaDyslipidaemiaNCT01221584AstraZeneca1,000
已完成
不适用
Study of Undertreatment of Patients With Dyslipidemia in BulgariaDyslipidemiaNCT01075594AstraZeneca2,500
已完成
不适用
Centralized Pan-Middle East Survey on the Undertreatment of HypercholesterolemiaHypercholesterolemiaNCT01025388AstraZeneca4,053